Edit
Report post Feedback

Is Atara Biotherapeutics (atra) a good stock to buy?

Atara Biotherapeutics, Inc.'s stock symbol is ATRA and currently trades under NASDAQ. It’s current price per share is approximately $0.80. What are your Atara Biotherapeutics, Inc. (ATRA) stock predictions? 7 Wall Street analysts have issued ratings. Currently, 2 analysts rated ATRA as Bullish, 1 rated it Bearish, and 4 rated it Neutral.

Is atra (atra) a good stock to buy?

7 Wall Street analysts have issued ratings. Currently, 2 analysts rated ATRA as Bullish, 1 rated it Bearish, and 4 rated it Neutral. This suggests a neutral outlook. View ATRA’s analyst predictions. 1 Seeking Alpha authors also rated the stock, and their ratings often outperform those of Wall Street analysts.

Who is Atara Biotherapeutics?

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients...

The World's Leading Crypto Trading Platform

Get my welcome gifts